PMID: 9180648May 1, 1997Paper

Comparison of a generic to disease-targeted health-related quality-of-life measures for multiple sclerosis

Journal of Clinical Epidemiology
B G VickreyG W Ellison

Abstract

Evaluation of the relative contributions of generic and disease-targeted measures to assessing health-related quality of life (HRQOL) for chronic conditions is needed to help in selection of appropriate measures. We administered a generic HRQOL measure (the Short Form-36 [SF-36]), three disease-targeted supplemental scales to the SF-36, and two disease-targeted HRQOL instruments to 171 adults with multiple sclerosis. Most scales yielded adequate variability, internal consistency reliability, and test-retest reliability. The relationship between each measure and four primary "criterion" variables were assessed: overall symptom severity in the prior year; ambulation status; days unable to work or attend school in the prior month: and a rating of overall quality of life. Results indicate that the disease-targeted scales provided unique information not captured by the generic measure. We conclude that if a generic measure of HRQOL is desirable for a given study of multiple sclerosis, additional information will be gained by supplementing that measure with selected scales.

Associated Clinical Trials

References

Apr 1, 1991·Western Journal of Nursing Research·E E Gulick
Aug 18, 1989·JAMA : the Journal of the American Medical Association·A R TarlovM Zubkoff
May 1, 1986·Journal of General Internal Medicine·A M JetteT L Delbanco
Mar 1, 1983·Annals of Neurology·C M PoserW W Tourtellotte
Jun 1, 1995·Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation·B G VickreyG W Ellison
Oct 1, 1993·Health Economics·R D HaysR M Mazel
Jun 1, 2000·Cleveland Clinic Journal of Medicine·H HoenigJ Galbraith

❮ Previous
Next ❯

Citations

Mar 15, 2005·Journal of Neurology·Anders RombergJuhani Ruutiainen
Jul 19, 2005·Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation·Stacey HartDavid C Mohr
Mar 21, 2006·Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation·Seung-June Oh, Ja Hyeon Ku
Apr 23, 2008·Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation·Katherine Froehlich-GrobeGlen W White
Aug 29, 2009·Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation·Carlos A BrownBarbara G Vickrey
Oct 26, 2005·Archives of Clinical Neuropsychology : the Official Journal of the National Academy of Neuropsychologists·Suzanne L Barker-Collo
Nov 1, 2002·Journal of the Neurological Sciences·Vallabh Janardhan, Rohit Bakshi
May 7, 2004·Spine·Megan DavidsonSophie Eyres
Jan 25, 2000·Journal of Neurology, Neurosurgery, and Psychiatry·J A FreemanA J Thompson
Aug 21, 2001·Journal of Neurology, Neurosurgery, and Psychiatry·J HobartA Thompson
Aug 20, 2002·Journal of Neurology, Neurosurgery, and Psychiatry·C PozzilliM Battaglia
Nov 26, 2003·Health and Quality of Life Outcomes·Catherine AcquadroIsabelle Mear
Jan 9, 2008·Health and Quality of Life Outcomes·C Allyson JonesKenneth G Warren
Sep 29, 2009·Vojnosanitetski pregled. Military-medical and pharmaceutical review·Darija Kisić TepavcevićJelena Drulović
Nov 7, 2001·Acta Neurologica Scandinavica·S FruehwaldU Baumhackl
Nov 20, 2012·Neurologia i neurochirurgia polska·Józef OparaWaldemar Brola
Dec 22, 2015·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·Elizabeth Goodwin, Colin Green
Dec 22, 2015·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·Nan LuoEcosse Lamoureux
Jun 5, 2003·Movement Disorders : Official Journal of the Movement Disorder Society·Mickie WelshUNKNOWN Parkinson Study Group
Dec 2, 2011·Journal of Evaluation in Clinical Practice·Elegance T P LamWen Wei Huang
Aug 16, 2005·Prostaglandins, Leukotrienes, and Essential Fatty Acids·Bianca Weinstock-GuttmanRichard Rudick
Oct 19, 2006·American Journal of Ophthalmology·Brian A RaphaelLaura J Balcer
Jul 15, 2003·Disability and Rehabilitation·Terry DilorenzoMary Ann Picone
Nov 18, 2003·Disability and Rehabilitation·Julián Benito-LeónAlex Mitchell
Mar 18, 2010·International Review of Psychiatry·Odysseas KargiotisPanagiotis Papathanasopoulos
Aug 4, 2007·Health and Quality of Life Outcomes·Louis S MatzaNicole Yurgin
Jan 15, 2015·The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques·Fraser MooreLiesly Lee
Oct 13, 2006·Health and Quality of Life Outcomes·Kristina Secnik BoyeRobert Brodows
Oct 28, 2008·Disability and Rehabilitation·K WyniaS A Reijneveld
Sep 1, 1999·Multiple Sclerosis : Clinical and Laboratory Research·J S FischerD Paty
Nov 29, 2001·Multiple Sclerosis : Clinical and Laboratory Research·M P AmatoL Rossi
Nov 7, 2000·Multiple Sclerosis : Clinical and Laboratory Research·A Feinstein
Mar 1, 2006·Clinical Rehabilitation·Angus ForbesPeter Griffiths
Mar 5, 2011·Multiple Sclerosis : Clinical and Laboratory Research·Line E HviidBonnie I Glanz

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation
B G VickreyG W Ellison
Journal of Neurology, Neurosurgery, and Psychiatry
A SolariP Mosconi
© 2021 Meta ULC. All rights reserved